Skip to main content
. 2020 Dec 1;76(3):653–658. doi: 10.1093/jac/dkaa499

Figure 2.

Figure 2.

Susceptibility of Elizabethkingia spp. to novel antibiotics. Due to the lack of CLSI breakpoints, susceptibility criteria were adapted from previous studies and are listed in Table S3. LCF, lascufloxacin; DFX, delafloxacin; CZA, ceftazidime/avibactam; FPZ, cefepime/zidebactam; IMR, imipenem/relebactam; MEV, meropenem/vaborbactam; OMC, omadacycline; ERV, eravacycline.